Buried in the Bulbous Book

Few if any members of Congress will read the entire Patient Protection and Affordable Care Act that Senate Majority Leader Harry Reid (D-Nev.) introduced last week, and people who have other things to do with their lives shouldn't even attempt to do so. But there are a few sections that could be compelling reading for biotech and pharma companies.

Executives struggling to keep emerging biotech companies alive can ignore most of the mammoth unified Senate healthcare reform bill and skip straight to page 2,057, where they'll find the "Qualifying Therapeutic Discovery Project Credit."...